Concepedia

Anna Junker

AJ

14

Publications

325

Citations

11

H-Index

2013

Active since

Affiliations

University of Münster(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

Centre for Human Drug Research

Leiden University

National Institutes of Health

Anna Junker is an author at University of Münster specializing in pharmacology, drug discovery, and medicine.

ORCID

Top concepts

Publications per year

2013–2022

14

Publications

14

Structure–Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors

Anna Junker, Christian Renn, Clemens Dobelmann et al. · Journal of Medicinal Chemistry · 2019 · 66 citations · Full text

Structure-Based Design of 3-(4-Aryl-1<i>H</i>-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y<sub>14</sub> Receptor Antagonists

Anna Junker, R. Balasubramanian, Antonella Ciancetta et al. · Journal of Medicinal Chemistry · 2016 · 52 citations · Full text

, , +14

Synthesis of Thiophene-Based TAK-779 Analogues by C–H Arylation

Anna Junker, Junichiro Yamaguchi, Kenichiro Itami et al. · The Journal of Organic Chemistry · 2013 · 29 citations

, , +10

Synthesis and Structure−Activity Relationships of Imidazopyridine/Pyrimidine‐ and Furopyridine‐Based Anti‐infective Agents against Trypanosomiases

Daniel Gedder Silva, Anna Junker, Shaiani Maria Gil de Melo et al. · ChemMedChem · 2020 · 28 citations · Full text

, , +18

Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease

Bengisu Turgutalp, Prabesh Bhattarai, Tuğba Erçeti̇n et al. · Journal of Medicinal Chemistry · 2022 · 24 citations · Full text

Rows per page

1–5 of 14